Disposable Insulin Nanopump for Diabetes Treatment
(Mini bomba-Chip (ultra diminuta) de insulina para controlar la diabetes).
Debiotech and STMicroelectronics today announced a strategic cooperation agreement aimed at manufacturing and delivering to the market a unique miniaturized insulin-delivery pump. The Nanopump, which relies on microfluidic MEMS (Micro-Electro-Mechanical System) technology, is a breakthrough concept that allows a tiny pump to be mounted on a disposable skin patch to provide continuous insulin infusion. The Nanopump is able to control delivery at the nanoliter level, very close to the physiological delivery of insulin. The device prevents over-dosing and detects under-delivery, occlusion, air bubbles and other potential malfunctions in the pump to further protect patients. As a disposable device, manufactured using high-volume semiconductor processing technologies, the MEMS-based Nanopump will also be much more affordable, allowing the patient or the health system to avoid the typical up-front investment associated with current pump solutions.
Today, existing insulin pumps are about the size of a pager. The new ST-enabled Debiotech miniaturized MEMS device is about one quarter the size of these existing pumps and can be worn as a nearly invisible patch on the skin. The small size frees the patient from concerns with holding the pump in place and concealing it under clothing. The highly miniaturized disposable insulin pump combines Debiotech’s expertise in insulin delivery with ST’s strengths in manufacturing high-volume silicon-based microfluidic devices.
Algo escueta la noticia, pero al menos parece que hay intención, tiempo, esfuerzo y dinero detrás de ella... en definitiva: intenciones para seguir mejorando "el asunto".
(Mini bomba-Chip (ultra diminuta) de insulina para controlar la diabetes).
Debiotech and STMicroelectronics today announced a strategic cooperation agreement aimed at manufacturing and delivering to the market a unique miniaturized insulin-delivery pump. The Nanopump, which relies on microfluidic MEMS (Micro-Electro-Mechanical System) technology, is a breakthrough concept that allows a tiny pump to be mounted on a disposable skin patch to provide continuous insulin infusion. The Nanopump is able to control delivery at the nanoliter level, very close to the physiological delivery of insulin. The device prevents over-dosing and detects under-delivery, occlusion, air bubbles and other potential malfunctions in the pump to further protect patients. As a disposable device, manufactured using high-volume semiconductor processing technologies, the MEMS-based Nanopump will also be much more affordable, allowing the patient or the health system to avoid the typical up-front investment associated with current pump solutions.
Today, existing insulin pumps are about the size of a pager. The new ST-enabled Debiotech miniaturized MEMS device is about one quarter the size of these existing pumps and can be worn as a nearly invisible patch on the skin. The small size frees the patient from concerns with holding the pump in place and concealing it under clothing. The highly miniaturized disposable insulin pump combines Debiotech’s expertise in insulin delivery with ST’s strengths in manufacturing high-volume silicon-based microfluidic devices.
Algo escueta la noticia, pero al menos parece que hay intención, tiempo, esfuerzo y dinero detrás de ella... en definitiva: intenciones para seguir mejorando "el asunto".
No hay comentarios:
Publicar un comentario